Literature DB >> 28956708

Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.

Cao Chen1, Xiao-Feng Xu1, Ren-Qing Zhang1,2, Yue Ma1, Yan Lv1, Jian-Le Li1, Qiang Shi1, Kang Xiao1, Jing Sun1, Xiao-Dong Yang1, Qi Shi1, Xiao-Ping Dong1.   

Abstract

α1-Antichymotrypsin (α1-ACT) belongs to a kind of acute-phase inflammatory protein. Recently, such protein has been proved exist in the amyloid deposits which is the hallmark of Alzheimer's disease, but limitedly reported in prion disease. To estimate the change of α1-ACT during prion infection, the levels of α1-ACT in the brain tissues of scrapie agents 263K-, 139A- and ME7-infected rodents were analyzed, respectively. Results shown that α1-ACT levels were significantly increased in the brain tissues of the three kinds of scrapie-infected rodents, displaying a time-dependent manner during prion infection. Immunohistochemistry assays revealed the increased α1-ACT mainly accumulated in some cerebral regions of rodents infected with prion, such as cortex, thalamus and cerebellum. Immunofluorescent assays illustrated ubiquitously localization of α1-ACT with GFAP positive astrocytes, Iba1-positive microglia and NeuN-positive neurons. Moreover, double-stained immunofluorescent assays and immunohistochemistry assays using series of brain slices demonstrated close morphological colocalization of α1-ACT signals with that of PrP and PrPSc in the brain slices of 263K-infected hamster. However, co-immunoprecipitation does not identify any detectable molecular interaction between the endogenous α1-ACT and PrP either in the brain homogenates of 263K-infected hamsters or in the lysates of prion-infected cultured cells. Our data here imply that brain α1-ACT is increased abnormally in various scrapie-infected rodent models. Direct molecular interaction between α1-ACT and PrP seems not to be essential for the morphological colocalization of those two proteins in the brain tissues of prion infection.

Entities:  

Keywords:  PrP; astrocytes; microglia; prion disease; α1-Antichymotrypsin

Mesh:

Substances:

Year:  2017        PMID: 28956708      PMCID: PMC5639854          DOI: 10.1080/19336896.2017.1349590

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  39 in total

Review 1.  The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature.

Authors:  G A Silverman; P I Bird; R W Carrell; F C Church; P B Coughlin; P G Gettins; J A Irving; D A Lomas; C J Luke; R W Moyer; P A Pemberton; E Remold-O'Donnell; G S Salvesen; J Travis; J C Whisstock
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

2.  Scrapie strains maintain biological phenotypes on propagation in a cell line in culture.

Authors:  C R Birkett; R M Hennion; D A Bembridge; M C Clarke; A Chree; M E Bruce; C J Bostock
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification.

Authors:  Itai Yanai; Hila Benjamin; Michael Shmoish; Vered Chalifa-Caspi; Maxim Shklar; Ron Ophir; Arren Bar-Even; Shirley Horn-Saban; Marilyn Safran; Eytan Domany; Doron Lancet; Orit Shmueli
Journal:  Bioinformatics       Date:  2004-09-23       Impact factor: 6.937

4.  Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.

Authors:  C R Abraham; T Shirahama; H Potter
Journal:  Neurobiol Aging       Date:  1990 Mar-Apr       Impact factor: 4.673

Review 5.  Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins.

Authors:  R Huber; R W Carrell
Journal:  Biochemistry       Date:  1989-11-14       Impact factor: 3.162

6.  Genetic association between susceptibility to Parkinson's disease and alpha1-antichymotrypsin polymorphism.

Authors:  M Yamamoto; I Kondo; N Ogawa; M Asanuma; Y Yamashita; Y Mizuno
Journal:  Brain Res       Date:  1997-06-06       Impact factor: 3.252

7.  Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA).

Authors:  Yoshiko Furiya; Makito Hirano; Norio Kurumatani; Takuya Nakamuro; Ryusuke Matsumura; Naonobu Futamura; Satoshi Ueno
Journal:  Brain Res Mol Brain Res       Date:  2005-08-18

8.  Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases.

Authors:  Gui-Rong Wang; Song Shi; Chen Gao; Bao-Yun Zhang; Chan Tian; Chen-Fang Dong; Rui-Min Zhou; Xiao-Li Li; Cao Chen; Jun Han; Xiao-Ping Dong
Journal:  BMC Infect Dis       Date:  2010-04-01       Impact factor: 3.090

9.  Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease.

Authors:  F Licastro; L Parnetti; M C Morini; L J Davis; D Cucinotta; A Gaiti; U Senin
Journal:  Alzheimer Dis Assoc Disord       Date:  1995       Impact factor: 2.703

10.  Brain microglia were activated in sporadic CJD but almost unchanged in fatal familial insomnia and G114V genetic CJD.

Authors:  Qi Shi; Wu-Ling Xie; Baoyun Zhang; Li-Na Chen; Yin Xu; Ke Wang; Ke Ren; Xiao-Mei Zhang; Cao Chen; Jin Zhang; Xiao-Ping Dong
Journal:  Virol J       Date:  2013-07-01       Impact factor: 4.099

View more
  4 in total

1.  Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance.

Authors:  Arianna Colini Baldeschi; Marco Zattoni; Silvia Vanni; Lea Nikolic; Chiara Ferracin; Giuseppina La Sala; Maria Summa; Rosalia Bertorelli; Sine Mandrup Bertozzi; Gabriele Giachin; Paolo Carloni; Maria Laura Bolognesi; Marco De Vivo; Giuseppe Legname
Journal:  J Med Chem       Date:  2022-06-30       Impact factor: 8.039

2.  Serpin Signatures in Prion and Alzheimer's Diseases.

Authors:  Marco Zattoni; Marika Mearelli; Silvia Vanni; Arianna Colini Baldeschi; Thanh Hoa Tran; Chiara Ferracin; Marcella Catania; Fabio Moda; Giuseppe Di Fede; Giorgio Giaccone; Fabrizio Tagliavini; Gianluigi Zanusso; James W Ironside; Isidre Ferrer; Giuseppe Legname
Journal:  Mol Neurobiol       Date:  2022-04-13       Impact factor: 5.682

Review 3.  Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases.

Authors:  Yanxia Jin; Weidong Wang; Qiyun Wang; Yueyang Zhang; Kashif Rafiq Zahid; Umar Raza; Yongsheng Gong
Journal:  Cancer Cell Int       Date:  2022-04-19       Impact factor: 6.429

4.  Significant enhanced expressions of aquaporin-1, -4 and -9 in the brains of various prion diseases.

Authors:  Qi Shi; Yue-Zhang Wu; Xuehua Yang; Kang Xiao; Adalaiti Maimaitiming; Li-Ping Gao; Cao Chen; Chen Gao; Yanjun Guo; Xiao-Ping Dong
Journal:  Prion       Date:  2019-01       Impact factor: 3.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.